Physician profile
Paul L Weidner
NPI 1164497889
$2,728.84
in general payments reported to CMS, 2019-2025
18 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,448 · 2020: $57.96 · 2021: $168 · 2022: $428 · 2023: $284 · 2024: $238 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $626.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,384.11 | 2019-2025 | Pangea |
| Ferring Pharmaceuticals INC. | $280.01 | 2022-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $254.62 | 2019-2024 | Orthovisc, Monovisc |
| Zimmer Biomet Holdings, INC. | $227.17 | 2022-2023 | Gel-One Cross-Linked Hyaluronate, Avenir |
| Ermi LLC | $101.26 | 2019-2024 | |
| Heron Therapeutics, INC. | $82.07 | 2021-2023 | Zynrelef |
| Pacira Therapeutics, INC. | $63.09 | 2019 | |
| Sanofi-Aventis U.S. LLC | $56.42 | 2019-2020 | |
| Acumed LLC | $49.68 | 2024 | Innate Implant, Acumed, Inframe Implant |
| Paladin Technology Solutions | $49.06 | 2024 | |
| Becton, Dickinson and Company | $42.42 | 2022 | |
| Djo, LLC | $34.28 | 2022 | |
| Wound Management Technologies, INC | $33.49 | 2019 | |
| Axogen | $15.80 | 2023 | Avance Nerve Graft |
| Pacira Pharmaceuticals Incorporated | $14.58 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $14.27 | 2022 | |
| Endo Pharmaceuticals INC. | $13.26 | 2019 | |
| Heraeus Medical, LLC. | $13.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Weidner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.